This is preventable, but only if we act now
A new study published in the New Zealand Medical Journal projects that stomach cancer diagnoses among Pacific peoples could nearly double by 2045, driven not by fate but by a preventable bacterial infection called H. pylori that takes root in childhood and waits. The research illuminates a disparity long embedded in the system: Pacific communities carry the highest infection and cancer rates yet receive the least testing and treatment. In this gap between burden and access lies both the crisis and the possibility — for if 40 to 60 percent of these cases are preventable, the question becomes not whether the tools exist, but whether the will and equity to deploy them do.
- A bacterium most people have never heard of is quietly shaping a cancer crisis — H. pylori infects 38% of Pacific peoples, nearly three times the European rate, and can spend decades turning silent inflammation into stomach cancer.
- The numbers are unambiguous and alarming: Pacific stomach cancer diagnoses are projected to climb from 45 to 87 per year by 2045, a 93% surge that dwarfs the national trend and will fall hardest on communities already carrying the heaviest burden.
- The cruelest dimension of this crisis is structural — Pacific families face the highest infection rates but the lowest access to testing and treatment, a paradox rooted in crowded living conditions, socioeconomic disadvantage, and a healthcare system that responds to symptoms rather than silent risk.
- Health officials are preparing screening trials and exploring integration of H. pylori testing into existing programmes, but researchers warn that any solution must be built with Pacific and Māori communities — not merely for them — to have any real chance of closing the gap.
- The projections are not a verdict but a warning: between 40 and 60 percent of these cases could be prevented, and every year without action is another generation of children acquiring an infection that may define their health decades from now.
A new study has issued a stark warning for Pacific communities in New Zealand: without intervention, stomach cancer cases among Pasifika people could nearly double over the next two decades, rising from 45 to 87 annual diagnoses by 2045 — a 93 percent increase that far outpaces national trends. The research, published in the New Zealand Medical Journal, was designed not as a prediction of inevitability but as a map of what happens if nothing changes.
At the center of the crisis is Helicobacter pylori, a bacterium that typically takes hold in childhood and can remain dormant for decades, quietly inflaming and damaging stomach tissue. Pacific peoples carry an infection rate of around 38 percent — nearly three times higher than European New Zealanders — a disparity shaped by crowded household conditions and socioeconomic disadvantage that accelerate person-to-person transmission.
What makes the projection especially urgent is that the disease is largely preventable. International evidence suggests 40 to 60 percent of stomach cancer cases could be avoided through early H. pylori detection and treatment. Yet Pacific communities face a painful paradox: the highest infection rates paired with the lowest rates of testing and access to care. Most people infected show no symptoms at all, meaning the gap in reactive healthcare leaves the majority undetected.
Health officials say screening trials are being prepared, with work underway to explore whether H. pylori testing could be folded into existing healthcare programmes as part of New Zealand's broader Cancer Action Plan. But researchers stress that any programme must be built with equity at its foundation — developed alongside Māori and Pacific providers and communities to ensure it is genuinely accessible and trustworthy, not simply available on paper.
The study offers a choice rather than a sentence. The projected rise is conditional on inaction. But time is not neutral — each year without intervention is another cohort of children potentially acquiring an infection that could define their health outcomes a generation from now.
A new study has delivered a stark warning for Pacific communities across New Zealand: without intervention, stomach cancer cases could nearly double over the next two decades. Researchers project that annual diagnoses among Pasifika people will climb from 45 to 87 by 2045—a 93 percent increase that far outpaces the national trend. The culprit is a bacterium most people have never heard of, one that often arrives in childhood and sits silently in the body for years before potentially turning deadly.
The research, published in the New Zealand Medical Journal, reveals a troubling disparity already baked into the present. Pacific people currently carry the highest stomach cancer burden in the country at 14.4 cases per 100,000 people, compared to 4.6 per 100,000 among European and other populations. The national stomach cancer rate is expected to rise nearly 50 percent by 2045, from around 500 cases annually to about 700. But for Māori and Pacific communities, the trajectory is steeper and more urgent. Dr. Nina Bevin, a health expert who spoke about the findings, framed the research as a call to action: the study was designed to show what happens if nothing changes, and to begin thinking about what can be done now.
The bacterial culprit is Helicobacter pylori, or H. pylori, one of the world's leading preventable causes of stomach cancer. The infection typically takes hold during childhood and can remain dormant for decades, causing chronic inflammation that gradually damages stomach cells. For Pacific peoples, infection rates stand at around 38 percent—nearly three times higher than the 13 percent rate among European New Zealanders and substantially higher than the 23 percent rate among Māori. The disparity is not random. H. pylori spreads person-to-person, and crowded household conditions accelerate transmission. Pacific families are statistically more likely to live in crowded homes, and the infection is strongly associated with socioeconomic disadvantage—a reality that shapes health outcomes across the region.
What makes this projection particularly urgent is that the disease is largely preventable. International evidence shows that between 40 and 60 percent of stomach cancer cases could be avoided through early testing and treatment of H. pylori. Yet Pacific communities face a cruel paradox: they have the highest infection rates but the lowest rates of testing and treatment. This gap in access sits at the heart of the health inequity the research exposes. Many people infected with H. pylori show no symptoms at all, meaning they remain unaware they carry a bacterium that, left untreated, can cause permanent stomach damage and eventually cancer.
Health officials acknowledge the problem and say work is already underway to address it. Dr. Karen Bartholomew, director of Health Gain Development, noted that several trials are being prepared to test different screening approaches, including whether H. pylori testing could be integrated into existing healthcare programs. The goal is to build evidence for a possible national screening programme aligned with New Zealand's Cancer Action Plan. Currently, people with gastric symptoms can see their primary care provider and may be tested if clinically indicated, but this reactive approach misses the asymptomatic majority who carry the infection.
Dr. Bevin emphasized that any new prevention programme must be designed with equity at its center. She stressed the importance of working directly with Māori and Pacific providers, communities, and whānau to ensure that whatever screening and treatment system is developed actually works for the people it aims to serve—that it is understandable, accessible, and something people can realistically engage with. The challenge is not just medical but structural: building trust, removing barriers, and ensuring that Pacific families are not left behind as new programmes roll out.
The research presents a choice. The projections are not inevitable; they are conditional on inaction. If screening and treatment programmes are expanded and made equitable, a substantial portion of the projected increase could be prevented. But time matters. Every year without intervention is another cohort of children potentially acquiring H. pylori infection, another generation facing elevated cancer risk in adulthood. The study is a map of what could happen. What happens next depends on whether the health system can move quickly enough to change the trajectory.
Citações Notáveis
We wanted to do this research so we could estimate how this problem might grow if we do nothing, and to start thinking about what action we can take to address the problem.— Dr. Nina Bevin, health expert
We've got to make sure that equity is at the centre of anything that we develop. We want to work with Māori and Pacific providers, communities, and whānau to make sure that whatever we design is something that works for us.— Dr. Nina Bevin
A Conversa do Hearth Outra perspectiva sobre a história
Why does H. pylori hit Pacific communities so much harder than others?
It's not that the bacteria itself discriminates. It's that the conditions that spread it—crowded households, limited access to healthcare, poverty—are more common in Pacific communities. The infection passes person-to-person, so when families live in tight quarters, it spreads faster. And once you have it, you need to know about it and get treated, which requires access to testing that hasn't been equally available.
So if we caught it early, we could prevent most of these cancers?
Yes. The research shows 40 to 60 percent of stomach cancers could be prevented through early detection and treatment. The bacteria doesn't have to become cancer. But that only works if people know they're infected and can actually get treatment.
What's stopping that from happening now?
Several things. Many people have no symptoms, so they don't know they carry it. And even when they do get tested, Pacific communities face lower rates of testing overall despite having higher infection rates. It's an access problem layered on top of a health literacy problem.
Is there a screening programme in place?
Not yet at a national level. Health officials are running trials to figure out how to do it effectively and equitably. The challenge is designing something that actually works for Pacific families, not just something imposed on them.
What does equitable design mean in this context?
It means working with Pacific communities from the start—asking what they need, how they prefer to access care, what barriers exist. It means making sure the programme is culturally appropriate and doesn't add burden. And it means ensuring that when screening starts, treatment is also available and accessible.
If nothing changes, what does the data say?
Stomach cancer cases in Pacific communities will nearly double by 2045. That's not a distant problem—it's people who are children now facing cancer in their 40s and 50s. The study is essentially saying: this is preventable, but only if we act.